Prediction of the dominating H3N2 influenza strain
Explicit fitness scores based on specific mutations
→ mutations in previously characterized epitopes
→ mutations that likely reduce fitness
→ mostly historically ascertained
Phylogenetic indicators to spot rapidly expanding clades
Laboratory data (antigenicity, virulence)
Human serology
____
Mutational signatures -- epitope mutations
Luksza and Laessig, Nature, 2014
Phylogenetic indicators -- LBI
RN, Russell, Shraiman, eLife, 2014
Hemagglutination Inhibition assays
Slide by Trevor Bedford
Antigenic distance tables
Long list of distances between sera and viruses
Tables are sparse, only close by pairs
Slide by Trevor Bedford
Integrating antigenic and molecular evolution -- ferret serology
Fitting frequency dynamics to mutations and sequence/variant features.
→ complex epistatic interactions prevent extrapolation to new variants
Using laboratory data to map effects of all possible mutations (deep mutational scanning).
→ immune escape can be assessed from sequence, virulence and fitness not
Too many aspects of SARS-CoV-2 evolution are unknown to make meaningful predictions.
____
Medium term dynamics of SARS-CoV-2 is very uncertain
Will we start seeing second and third generation variants, as opposed to sister variants?
Will we the saltatory dynamics with heavily diverged variants continue?
Will a more diverse immunity landscape slow down future variant dynamics?
Will waning/antigenic evolution slow down and give rise to annual or even rarer waves?
____
So far, independent variants have dominated successively